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Abstract: Background: Periodontitis is a disease that leads to serious functional and esthetic
dysfunctions. Periodontitis exists in different forms, and its etiology is related to multiple
component causes. Two key processes involved in the evolution of this pathology are
angiogenesis and inflammatory infiltrate. The aim of this study was to understand if
important factors such as smoking, gender, age, plaque, pus, and probing pocket depth could
influence the histomorphological pattern of generalized stage III–IV, grade C periodontitis
(GPIII–IVC), which is a particular form of periodontitis. Methods: Eighteen subjects with
GPIII–IVC were enrolled in this study. The percentage of inflammatory cells and the
vascular area were measured and evaluated in relation to each periodontal disease-associated
factor. Results: Females showed a significant increase in the percentage of inflammatory cells
compared to males (6.29% vs. 2.28%, p-value = 0.020) and it was higher in non-smokers than
in smokers (4.56% vs. 3.14%, p-value = 0.048). Young patients showed a significant increase in
vascular area percentage compared to older patients (0.60% vs. 0.46%, p-value = 0.0006) and this
percentage was also higher in non-smokers compared to smokers (0.41% vs. 0.55%, p-value = 0.0008).
The vascular area was also more than halved in subjects with residual plaque on tooth surfaces
(0.74% vs. 0.36%, p-value = 0.0005). Conclusions: These results suggested that even if these factors
are commonly related to the worsening of periodontal status, some of them (pus and periodontal
probing depth (PPD)) do not affect the inflammatory and vascular patterns.
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1. Introduction
Periodontitis is a disease that, if untreated, leads to serious functional and aesthetic impairments,
as well as a strong conditioning of social life, resulting in impairment in life quality [1].
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This disease is characterized by a microbially-associated, host-mediated inflammation that results
in the loss of periodontal attachment, clinically detected as clinical attachment loss (CAL) [2]. If not
treated, periodontitis can result in impaired occlusion, occasional pain, discomfort, and, eventually,
tooth loss [3].
In 2018, the American Academy of Periodontology and the European Federation of Periodontology
published a new classification of periodontal diseases. Here is shown a periodontitis case definition
system based on a staging and grading framework. While stages I to IV are defined based on the
severity and complexity of management, grades A to C evidence the disease progression rate in three
categories: slow, moderate, and rapid. Depending on disease distribution and extent, periodontitis can
be categorized into a localized (<30% of teeth involved) generalized or molar/incisor pattern [4].
The worst periodontal condition is evident in patients with generalized stage III–IV, grade C
periodontitis. In these situations, significantly rapid progressive damage to the attachment apparatus,
which can lead (especially in stage IV) to tooth loss and occlusion impairment, is appreciated [4].
About the etiology of this pathology, periodontitis is a complex disease with a genetic and
epigenetic basis and/or causes related to patient behaviors (e.g., medications or environmental factors),
which contribute to the progression of the periodontal lesion. In addition to such ‘patient-specific risk
factors,’ there are also ‘site-specific characteristics,’ such as anatomical factors, which may promote the
development of a lesion [1].
Periodontal lesions induce tissue changes inside the gum and the alveolar bone. The constant
action of the etiological factors, which induces and sustains pathological changes, can induce irreversible
changes. Angiogenesis together with inflammatory infiltrate are associated with the evolution of
gingival inflammatory processes [5,6]. During gingival inflammation, inflammatory infiltrates represent
an increasing part within the connective tissue causing collagen degradation or fibrotic reaction [7,8]
by stimulating the effects of inflammatory mediators of the connective tissue [9,10]. In addition,
inflammation is associated with pathological angiogenesis and a high number of newly formed blood
vessels that can be quantified as micro-vessel density (MVD) [6–11].
Considering the involvement of these two processes in GPIII–IVC pathogenesis, the aim of our
study was to evaluate these histomorphological alterations in relation to some important factors
(e.g., smoking, gender, age, plaque, pus, and PPD (probing pocket depth)), known as periodontal
disease-associated factors. In particular, our null hypothesis had been to find a statistically significant
major mean percentage of the vascular area and inflammatory cells in non-smoker patients due to
the effects of smoking on biological tissues. GPIII–IVC patients have been chosen to better define the
histomorphological characteristics of a low prevalence illness.
2. Materials and Methods
2.1. Study Design and Ethical Approval
This retrospective observational study was conducted at the Dental Clinic “Lidia Verza,” University
of Brescia, Italy, from January 2014 to November 2016. The study protocol was reviewed and approved
by the ethics committee of “AO Spedali Civili” Hospital of Brescia (protocol n◦ 1473) (0059683,
18/12/2013) and conducted in accordance with the Helsinki Declaration. Written informed consent was
obtained from all patients.
2.2. Patients and Collection of the Samples
Eighteen subjects were enrolled in this study. The inclusion criteria were age older than 18 years;
no systemic illnesses or disorders; no medical treatment that may impair healing (immunodepression,
immunosuppression, diabetes, etc.); diagnosis of GPIII–IVC [4]; the presence of at least five teeth in
each quadrant; and the ability and willingness to give written informed consent.
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The exclusion criteria included pregnant or breastfeeding women; women practicing birth control
methods; cancer; allergy or other severe adverse reactions to amoxicillin and metronidazole; use of
local and/or systemic antibiotics in the 6 months previous to the beginning of the study.
Age, gender, smoking habits, and clinical and dental history were collected during clinical
assessments. Pocket probing depth (PPD), clinical attachment level (CAL), gingival margin recession
(GMR), bleeding on probing (BoP), and the plaque index (PI) using a periodontal probe with a diameter
of 0.5 millimeters (UNC 15, Hu-Friedy Italy, Milan, Italy) were evaluated.
The collection of the samples was carried out under topical anesthesia with 2% mepivacaine and
epinephrine 1:100,000 [7,8].
Hopeless [12] and mono- and multi-rooted teeth were selected (intra-radicular tissue was
not considered). Clinical data were collected, and six sites for teeth were tested. Gingival
biopsies (2 mm × 2 mm) from the attached tissue around a selected natural tooth were taken
by scalpel (15C, Hu-Friedy Italy, Milan, Italy) from the gingival margin of the deepest sites
(PPD ≥5 mm). Tissue samples were fixed in 10% buffered formalin (pH 7.0–7.2) for 24 hours,
dehydrated, and embedded in paraffin according to standard procedures. Serial sections (7-µm thick)
were cut by a microtome (Microm HM 325, Thermo Scientific, Walldorf, Germany) and collected on
poly-l-lysine-coated glass slides.
2.3. Histomorphometric Analysis
Sections were deparaffinized in xylene, rehydrated, and stained with hematoxylin–eosin staining
(Bio-Optica, Milan, Italy) and Masson–Goldner trichrome staining (Merck KGaA, Darmstadt, Germany)
for the evaluation of the percentage of inflammatory cells and the vascular area (Figure 1).
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were analyzed by an optical light microscope (Olympus BX50, Olympus, Hamburg, Germany).
Histomorphometric analyses were performed by two blinded investigators at the Section of Anatomy
and Physiopathology of the University of Brescia. Quantitative analysis of the percentage of
inflammatory cells and the vascular area were performed using a camera equipped with an image
analysis system (Image-Pro Premier 9.1; Immagini e Computer, Milan, Italy).
2.4. Statistical Analysis
Statistical analyses were performed by statistician from the University of Brescia.
As the percentage of non-smokers who generally attend the clinic is about 60%, the sample size
was calculated assuming a 2 vs. 3 ratio between arms (smokers vs. non-smokers). A sample size of 18
subjects (11 non-smokers and 7 smokers) is sufficient to detect a clinically important difference of 0.45%
between groups in reducing the vascular area, assuming a mean in healthy and non-smoking patients
of 1% [13], a common standard deviation of 0.3% with 80% power, and a 5% level of significance.
Similarly, as the mean of inflammatory infiltrates reported by literature in healthy and non-smoking
patients is 9% with a standard deviation of 1.5% [1], assuming a 2.5% reduction in smokers (mean 6%),
a sample size of 16 patients (10 non-smokers and 6 smokers) would deliver an 80% power at a 5% level
of significance.
In order to consider both aims, 18 patients were enrolled in this study.
The binary coded variable BoP was summarized as counts and percentages. Continuous variables
such as PPD and CAL loss were summarized as geometric mean and standard deviation (sd). Due to
the high number of zeros, the gingival recession was summarized both as the percentage of zero values
and the geometric mean and sd of non-zero values.
Laboratory data on inflammatory infiltrates and alveolar areas were recorded as within patient
averages and standard deviations; therefore, statistical analyses accounted for measurement precision
using inverse variance weighting. We used univariate linear regression models to evaluate the
relationship between log-transformed outcome variables (inflammatory infiltrate and vascular area)
and clinical determinants: gender (male/female), age (coded as <51 and ≥ 51 years old), smoking
habit (smoker/non-smoker), PPD (coded as <9 mm and ≥9 mm), presence of plaque on tooth surface
(yes/no), and pus (yes/no). The results are reported as the estimates and 95% confidence intervals.
All analyses were performed using the statistical software R (version 3.5.2, https://www.R-project.org/.)
with a significance level of 5%. The sample size was computed using G*Power (version 3.1,
http://www.gpower.hhu.de/).
3. Results
Out of 18 patients, 72% were females, 55.6% were more than 51 years old and smokers. About
two-thirds of the subjects had plaque on the tooth surface and pus. Full mouth means of PPD, CAL,
GMR (different from 0), and BoP were 3.46 mm, 4.03 mm, 2.39 mm, and 49%, respectively (Table 1).
Table 1. Clinical characteristics of patients (total mouth).
Mean (sd)
PPD (mm) 3.46 (1.79)
CAL loss (mm) 4.03 (1.84)
Gingival recession (, 0) 2.39 (1.73)
%
Gingival recession = 0 74.6
Bleeding on probing 49.0
Females showed a significant increase in inflammatory infiltrate compared to males (6.29% vs.
2.28%, p-value = 0.020) and this increase was also higher in non-smokers than in smokers (4.56% vs.
3.14%, p-value = 0.048).
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Considering the vascular area, young patients showed a significant increase compared to older
patients (0.60% vs. 0.46%, p-value = 0.0006) and this increase was also higher in non-smokers than
smokers (0.41% vs. 0.55%, p-value = 0.0008). The vascular area was also more than halved in subjects
with residual plaque on the tooth surfaces (0.74% vs. 0.36%, p-value = 0.0005), see Table 2.
Table 2. Mean percentage [and 95% CI] of inflammatory infiltrated and vascular area. * Raw log-means
were estimated weighting for the inverse of variance within a patient and then transformed through
exponential function. Only p-values of variables selected through backward regression models
are reported.
Mean Percentage of Inflammatory Infiltrates Mean Percentage of Vascular Area
Overall Raw Weighted Mean * 4.38% 0.24%
Gender
Female
Male
p-value
6.29% [3.21; 12.30]
2.28% [0.86; 6.04]
0.020
0.47% [0.22; 0.93]
0.58% [0.22; 1.54]
-
Age (median)
<51 years old
≥51 years old
p-value
3.21% [1.16; 8.88]
4.46% [2.54; 7.82]
-
0.60% [0.22; 1.65]
0.46% [0.23; 0.86]
0.006
Smoking habit
Non-smokers
Smokers
p-value
4.56% [2.06; 10.09]
3.14% [1.44; 6.85]
0.048
0.55% [0.32; 1.31]
0.41% [0.16; 1.06]
0.008
PPD (median)
<9
≥9
p-value
3.61% [1.66; 7.85]
3.97% [1.84; 8.58]
-
0.55% [0.28; 1.07]
0.59% [0.18; 1.31]
-
Plaque
Yes
No
p-value
3.01% [2.02; 4.49]
4.76% [1.53; 14.77]
0.14
0.36% [0.17; 0.77]
0.74% [0.30; 1.77]
0.0005
Pus
Yes
No
p-value
3.67% [1.29; 10.42]
3.90% [2.00; 7.61]
-
0.51% [0.12; 2.23]
0.53% [0.39; 0.71]
-
4. Discussion
The present retrospective observational study aimed to understand the influence of smoking,
gender, age, plaque, pus, and probing pocket depth on the histomorphological pattern of GPIII–IVC.
Females showed a significant increase in inflammatory infiltrate compare to males (and it was
higher in non-smokers than in smokers). Considering the vascular area, young patients showed
a significant increase compared to older patients and it was higher in non-smokers than smokers.
Our results showed that the vascular area was also more than halved in subjects with residual plaque
on tooth surfaces.
Periodontal disease and its related risk factors have been studied with growing interest [14–16].
This increasing investigation is due to the important scientific evidence that shows a variety of systemic
diseases and conditions that can affect the course of periodontitis or have a negative impact on
the periodontium (e.g., genetic disorders, acquired disorders, immunodeficiency and inflammatory
diseases) [17]. In addition, a recent study has pointed out that periodontitis is strongly associated
with oral squamous cell carcinoma (OSCC) and subjects with periodontitis are 3.7 times more likely to
have OSCC than subjects without periodontitis [18]. An abnormal inflammatory response to some
periodontal pathogenic bacteria belonging to the red complex (e.g., Tannerella Forsythia) including
pro-inflammatory cytokines (IL-1β and IL-6) overexpressed by CD4+ T helper cells and TNF-α, and the
presence of other molecules such as gingipain K produced by Porphyromonas gingivalis affecting the
host’s immune system by the degradation of immunoglobulins and the complement system (C3 and C5
components), are suggested as the base of the increased risk of head and neck cancer development [19],
as well as the occurrence of the same lifestyle-related risk factors including tobacco smoking.
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With this assumption, we decided to discuss the results factor by factor for simplifying
the comprehension.
4.1. Gender
Women showed a statistically significantly higher percentage of inflammatory cells with respect
to men and a non-significant reduction in the percentage of the vascular area. In the literature, gender
differences in periodontal diseases have been reported. The authors affirmed that men seemed to
be more susceptible to the risk of periodontal disease than women; on the contrary, men did not
show a higher risk of more rapid periodontal destruction than women [20]. This difference could be
considered to understand our results. However, additional studies aimed at evaluating the incidence
of gender in the characterization of the vascular and inflammatory patterns of periodontal disease
should be conducted.
4.2. Age
Our results showed a significant decrease in the percentage of the vascular area in patients older
than 50 years. These data are in accordance with Preshaw et al. [21] who asserted that the immune
system in old age is compromised by physiological changes, where there is a concomitant decrease in
blood vessel density with increasing age.
4.3. Smoking
Tobacco and its oxidation products are involved in the progression and clinical alterations of
periodontal diseases. Prakash et al. [21] reported a significant decrease in microvascular density and
inflammatory cell percentage in smokers with periodontitis compared to non-smokers. According to
the literature, our results confirm a significant decrease in the percentage of the vascular area and the
inflammatory cell percentage in smoker patients affected by GPIII–IVC [21,22].
4.4. Pocket Probing Depth
A periodontal pocket is defined as a pathologically deepened gingiva sulcus, according to the
definition reported by the American Academy of Periodontology. It occurs with the destruction of the
supporting periodontal tissue and migration of alveolar bone, periosteum, and periodontal ligament
versus the tooth apex.
The vascular density of the marginal gingiva is supported by arteries that extend into the
periodontal ligament and the alveolar bone and periosteum [23]. Consequently, we can speculate that
vascularization of the marginal gingiva should be more altered in relation to the pocket depth. This
concept is supported by our results, which showed a non-significant decrease in the mean percentage
of the vascular area and a statistically non-significant increase in the percentage of inflammatory cells
when a PPD ≥9 mm was recorded.
4.5. Plaque
The percentage of the vascular area was statistically significantly higher in the no plaque group
than in the plaque group. These data are difficult to explain considering the multifactorial etiology of
GPIII–IVC [1]. The concomitant decrease in the percentage of inflammatory cells was explained by
Sreedevi et al. [24]. In fact, they reported that suppression of the vascular inflammatory reaction could
be linked to an impairment in the defense mechanisms and more susceptibility to plaque infection.
It means that a higher vascular area in these kinds of susceptible patients could not be related to a
relevant quantity of plaque at a level site. Moreover, a non-statistically significant augmentation of the
percentage of inflammatory infiltrates was appreciated in the site with no plaque.
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4.6. Pus
Considering the presence/absence of pus, no significant differences were observed. However, this
factor should be investigated more.
Taking the statistical analysis into consideration, even if the above-considered factors are often
commonly related to the worsening of periodontal status, the most significant one is smoking. Its effect
contributes to the histopathological alteration, possibly worsening the clinical periodontal condition.
5. Conclusions
It is known that during gingival inflammation, inflammatory cells represent an increasing part
within the connective tissue [8,9] and inflammation is associated with the activation of pathological
angiogenesis and a high number of newly formed blood vessels [6,11].
In this study, we did not compare the percentage of the vascular area and inflammatory cells with
healthy patients, but we evaluated how some factors (smoking, age, PPD, plaque) influenced these
percentages in GPIII–IVC patients.
Within the limitations of the present study—the sample size—our results show a significant
decrease in the percentage of the vascular area in association with smoking, age, and plaque and of
inflammatory cell percentage in association with gender and smoking. The most significant effect is
related to smoking in patients with a similar periodontal condition. For the future, new Randomized
Clinical Trials – RCTs will be needed to verify whether smoking is a key factor in inflammatory and
vascular periodontal alteration.
Author Contributions: B.B., G.G. and M.M. conceived and designed the experiments; B.B.; E.B.; E.S. performed
the experiments; S.C. and V.C. analyzed the data; L.R. contributed reagents/materials/analysis tools; B.B.; G.G.;
M.M. wrote the paper.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Meyle, J.; Chapple, I. Molecular aspects of the pathogenesis of periodontitis. Periodontol. 2000 2015, 69, 7–17.
[CrossRef] [PubMed]
2. Tonetti, M.S.; Greenwell, H.; Kornman, K.S. Staging and grading of periodontitis: Framework and proposal
of a new classification and case definition. J. Clin. Periodont. 2018, 45, 149–161. [CrossRef] [PubMed]
3. Pihlstrom, B.L.; Michalowicz, B.S.; Johnson, N.W. Periodontal diseases. Lancet 2005, 366, 1809–1820.
[CrossRef]
4. Caton, J.C.; Armitage, G.; Berglundh, T.; Chapple, I.L.C.; Jepsen, S.; Kornman, K.S.; Mealey, B.L.;
Papapanou, P.N.; Sanz, M.; Tonetti, M. A new classification scheme for periodontal and peri-implant
diseases and conditions—Introduction and key changes from the 1999 classification. J. Clin. Periodont. 2018,
45, 1–8. [CrossRef] [PubMed]
5. Cornelini, R.; Artese, L.; Rubini, C.; Fioroni, M.; Ferrero, G.; Santinelli, A.; Piattelli, A. Vascular
endothelial growth factor and microvessel density around healthy and failing dental implants. Int. J.
Oral Maxillofac. Implants 2001, 16, 389–393. [PubMed]
6. Kasprzak, A.; Surdacka, A.; Tomczak, M.; Konkol, M. Role of high endothelial postcapillary venules and
selected adhesion molecules in periodontal diseases: A review. J. Periodontal. Res. 2013, 48, 1–21. [CrossRef]
[PubMed]
7. Borsani, E.; Salgarello, S.; Mensi, M.; Boninsegna, R.; Stacchiotti, A.; Rezzani, R.; Sapelli, P.; Bianchi, R.;
Rodella, L.F. Histochemical and immunohistochemical evaluation of gingival collagen and metalloproteinases
in peri-implantitis. Acta Histochem. 2005, 107, 231–240. [CrossRef] [PubMed]
8. Buffoli, B.; Dalessandri, M.; Favero, G.; Mensi, M.; Dalessandri, D.; di Rosario, F.; Stacchi, C.; Rezzani, R.;
Salgarello, S.; Rodella, L.F. AQP1 expression in human gingiva and its correlation with periodontal and
peri-implant tissue alterations. Acta Histochem. 2014, 116, 898–904. [CrossRef]
Biomedicines 2019, 7, 43 8 of 8
9. Page, R.C.; Schroeder, H.E. Pathogenesis of inflammatory periodontal disease. A summary of current work.
Lab. Investig. 1976, 34, 235–249.
10. Younes, R.; Ghorra, C.; Khalife, S.; Igondjo-Tchen-Changotade, S.; Yousfi, M.; Willig, C.; Senni, K.; Godeau, G.;
Naaman, N. Pertinent cell population to characterize periodontal disease. Tissue Cell 2009, 41, 141–150.
[CrossRef]
11. Vladau, M.; Cimpean, A.M.; Balica, R.A.; Jitariu, A.A.; Popovici, R.A.; Raica, M. VEGF/VEGFR2 Axis in
Periodontal Disease Progression and Angiogenesis: Basic Approach for a New Therapeutic Strategy. In Vivo
2016, 30, 53–60. [PubMed]
12. Know, V.; Caton, J.C. Commentary: Prognosis revisited a system for assigning periodontal prognosis.
J. Periodontol. 2007, 78, 2063–2071.
13. Preshaw, P.M.; Henne, K.; Taylor, J.J.; Valentine, R.A.; Conrads, G. Age-related changes in immune function
(immune senescence) in caries and periodontal diseases: A systematic review. J. Clin. Periodontol. 2017, 44,
S153–S177. [CrossRef] [PubMed]
14. Meyer-Bäumer, A.; Pritsch, M.; Cosgarea, R.; el Sayed, N.; Kim, T.S.; Eickholz, P.; Pretzl, B. Prognostic value
of the periodontal risk assessment in patients with aggressive periodontitis. J. Clin. Periodontol. 2012, 39,
651–658. [CrossRef] [PubMed]
15. Tomasi, C.; Leyland, A.H.; Wennström, J.L. Factors influencing the outcome of non-surgical periodontal
treatment: A multilevel approach. J. Clin. Periodontol. 2007, 34, 682–690. [CrossRef] [PubMed]
16. Lang, N.P.; Tonetti, M.S. Periodontal risk assessment (PRA) for patients in supportive periodontal therapy
(SPT). Oral Health Prev. Dent. 2003, 1, 7–16. [PubMed]
17. Jepsen, S.; Caton, J.G.; Albandar, J.M.; Bissada, N.F.; Bouchard, P.; Cortellini, P.; Demirel, K.; de Sanctis, M.;
Ercoli, C.; Fan, J. Periodontal manifestations of systemic diseases and developmental and acquired conditions:
Consensus report of workgroup 3 of the 2017 World Workshop on the Classification of Periodontal and
Peri-Implant Diseases and Conditions. J. Periodontol. 2018, 89, S237–S248. [CrossRef]
18. Shin, Y.J.; Choung, H.W.; Lee, J.H.; Rhyu, I.C.; Kim, H.D. Association of periodontitis with Oral Cancer:
A Case-Control Study. J. Dent. Res. 2019. [CrossRef]
19. Malinowski, B.; We˛sierska, A.; Zalewska, K.; Sokołowska, M.M.; Bursiewicz, W.; Socha, M.; Ozorowski, M.;
Pawlak-Osin´ska, K.; Wicin´ski, M. The role of Tannerella forsythia and Porphyromonas gingivalis in
pathogenesis of esophageal cancer. Infect. Agent. Cancer 2019. [CrossRef]
20. Shiau, H.J.; Reynolds, M.A. Sex differences in destructive periodontal disease: Exploring the biologic basis.
J. Periodontol. 2010, 81, 1505–1517. [CrossRef]
21. Prakash, P.; Rath, S.; Mukherjee, M.; Malik, A.; Boruah, D.; Sahoo, N.K.; Dutta, V. Comparative
evaluation of the marginal gingival epithelium in smokers and nonsmokers: A histomorphometric and
immunohistochemical study. Int. J. Periodontics Restor. Dent. 2014, 4, 781–786. [CrossRef] [PubMed]
22. Calsina, G.; Ramón, J.M.; Echeverría, J.J. Effects of smoking on periodontal tissues. J. Clin. Periodontol. 2002,
29, 771–776. [CrossRef] [PubMed]
23. Lindhe, J.; Lang, N.P.; Karring, T.; Berglundh, T.; Giannobile, W.V. Clinical Periodontology and Implant Dentistry,
5th ed.; Blackwell: Oxford, UK, 2008.
24. Sreedevi, M.; Ramesh, A.; Dwarakanath, C. Periodontal status in smokers and nonsmokers: A clinical,
microbiological, and histopathological study. Int. J. Dent. 2012, 2012, 571590. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
